Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed attachment file name title grouped question UIN question first answered answering member label
tabling member	label

Search

418384

registered interest
date	11/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Fluoride: Drinking Water
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government whether they have plans to make representations to Manchester City Council to give further consideration to fluoridation of the water supply in Greater Manchester; and whether any such representations will take account of the lower level of tooth decay amongst children in Birmingham, where the water supply has been fluoridated since 1964.
tabling member printed	Baroness Gardner of Parkes
uin	HL2178
answer	answer is ministerial correction date of answer 21/09/2015 answer text <p>It has been the policy of successive governments that decisions on water fluoridation are best taken locally. The Health and Social Care Act 2012 gave powers to upper tier and unitary local authorities to make proposals in relation to fluoridation.</p><p> </p><p> </p><p> </p><p>In 2014 Public Health England published a water fluoridation health monitoring report which showed lower levels of tooth decay in areas with water fluoridation.</p><p> </p><p> </p><p> </p><p>Public Health England has also, in 2014, published an evidence informed toolkit for local authorities to support them in planning, reviewing and commissioning oral health improvement interventions for children and young people, including the potential role of water fluoridation.</p><p> </p> answering member printed Lord Prior of Brampton question first answered 21/09/2015 15:12:30 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	3596 label Biography information for Baroness Gardner of Parkes

418385

registered interest
date	11/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Breast Cancer: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what assessment they have made of the number of lives that might be saved per annum from licensing bisphosphonates for the treatment of early post-menopausal breast cancer.
tabling member printed	Lord MacKenzie of Culkein
uin	HL2179
answer	answer is ministerial correction date of answer 22/09/2015 answer text <p>Neither the Department nor NHS England have made an assessment of the number of lives that might be saved per annum from licensing bisphosphonates for the treatment of early post-menopausal breast cancer.</p><p> </p><p> </p><p> </p><p>Doctors can already prescribe a drug outside its licensed indications where they judge it to be the most clinically appropriate treatment for an individual patient.</p><p> </p> answering member printed Lord Prior of Brampton grouped question UIN HL2180 question first answered 22/09/2015 10:19:17 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	2507 label Biography information for Lord MacKenzie of Culkein

418386

registered interest
date	11/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Breast Cancer: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government whether doctors are free to prescribe bisphosphonates in the treatment of early stage breast cancer despite the fact that it is not presently licensed for that purpose.
tabling member printed	Lord MacKenzie of Culkein
uin	HL2180
answer	answer is ministerial correction date of answer 22/09/2015 answer text <p>Neither the Department nor NHS England have made an assessment of the number of lives that might be saved per annum from licensing bisphosphonates for the treatment of early post-menopausal breast cancer.</p><p> </p><p> </p><p> </p><p>Doctors can already prescribe a drug outside its licensed indications where they judge it to be the most clinically appropriate treatment for an individual patient.</p><p> </p> answering member printed Lord Prior of Brampton grouped question UIN HL2179 question first answered 22/09/2015 10:19:18 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	2507 label Biography information for Lord MacKenzie of Culkein

418387

registered interest
date	11/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Breast Cancer: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what is the cost to the National Health Service of bisphosphonates and whether they will take steps to encourage the National Institute for Health and Care Excellence to consider the evidence base for the prescription of these drugs in treatment of early stage breast cancer.
tabling member printed	Lord MacKenzie of Culkein
uin	HL2181
answer	answer is ministerial correction date of answer 22/09/2015 answer text <p>The net ingredient cost of prescription items dispensed in the community in England for bisphosphonates<sup>1</sup> in 2014, was £16.813 million<sup>2</sup>.</p><p> </p><p> </p><p> </p><p>In secondary care, the cost in 2014 was £35.841 million<sup>3</sup>.</p><p> </p><p> </p><p> </p><p>The National Institute for Health and Care Excellence (NICE) has published clinical guidelines on early and locally advanced breast cancer and advanced breast cancer, published in February 2009, and familial breast cancer published in June 2013. NICE periodically reviews its guidance to take account of new and emerging evidence.</p><p> </p><p> </p><p> </p><p>A copy of these clinical guidelines are attached.</p><p> </p><p><em> </em></p><p> </p><p><sup>1 </sup>Bisphosphonates are defined as those included in paragraph 6.6.2 (Bisphosphonates and other drugs affecting bone metabolism) of the British National Formulary (BNF) but excluding denosumab and strontium ranelate.</p><p> </p><p><sup>2 </sup>Source: Prescription Cost Analysis (PCA) provided by the Health and Social Care Information Centre</p><p> </p><p><sup>3 </sup>Source: Hospital Pharmacy Audit Index (HPAI) provided by IMS Health</p><p> </p><p> </p><p> </p> answering member printed Lord Prior of Brampton attachment 1 file name HL2181 Cost ofbisphosphonates to the NHS.doc attachment 1.pdf title Early and locally advanced breast cancer guideline 2 file name HL2181 Cost ofbisphosphonates to the NHS.doc attachment 2.pdf title Advanced breast cancer guidelines 3 file name HL2181 Cost ofbisphosphonates to the NHS.doc attachment 3.pdf title Familial breast cancer guidelines question first answered 22/09/2015 10:20:06 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	2507 label Biography information for Lord MacKenzie of Culkein

418448

registered interest
date	11/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Smoking
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what information his Department holds on how many people of what age ranges gave up smoking in each of the last five years.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	10021
answer	answer is ministerial correction date of answer 21/09/2015 answer text <p>The Health and Social Care Information Centre collects this information on behalf of the Department and it is made publicly available at the following web addresses:</p><p> </p><p> </p><p> </p><p><a href="http://www.hscic.gov.uk/catalogue/PUB00417/nhs-stop-smok-serv-eng-2010-2011-tab.xls" target="_blank">http://www.hscic.gov.uk/catalogue/PUB00417/nhs-stop-smok-serv-eng-2010-2011-tab.xls</a></p><p> </p><p> </p><p> </p><p><a href="http://www.hscic.gov.uk/catalogue/PUB07011/stat-stop-smok-eng-apr-11-mar-12-tab1.xls" target="_blank">http://www.hscic.gov.uk/catalogue/PUB07011/stat-stop-smok-eng-apr-11-mar-12-tab1.xls</a></p><p> </p><p> </p><p> </p><p><a href="http://www.hscic.gov.uk/catalogue/PUB12228/stat-stop-smok-serv-eng-apr-12-mar-13-tab1.xls" target="_blank">http://www.hscic.gov.uk/catalogue/PUB12228/stat-stop-smok-serv-eng-apr-12-mar-13-tab1.xls</a></p><p> </p><p> </p><p> </p><p><a href="http://www.hscic.gov.uk/catalogue/PUB14610/stat-stop-smok-serv-eng-apr-13-mar-14-tab.xlsx" target="_blank">http://www.hscic.gov.uk/catalogue/PUB14610/stat-stop-smok-serv-eng-apr-13-mar-14-tab.xlsx</a></p><p> </p><p> </p><p> </p><p><a href="http://www.hscic.gov.uk/catalogue/PUB18002/stat-stop-smok-serv-eng-annual-1415.xlsx" target="_blank">http://www.hscic.gov.uk/catalogue/PUB18002/stat-stop-smok-serv-eng-annual-1415.xlsx</a></p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 21/09/2015 10:05:51 answering member 3918 label Biography information for Jane Ellison
tabling member	4131 label Biography information for Jim Shannon

418465

registered interest
date	11/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will bring forward proposals for an independent Royal Commission on the future of the NHS.
tabling member constituency	Leeds North West
tabling member printed	Greg Mulholland
uin	9970
answer	answer is ministerial correction date of answer 21/09/2015 answer text <p>There is no plan to launch a Royal Commission into the future of the National Health Service. The Government remains committed to the principles of the NHS, enshrined in the NHS Constitution and in working with the NHS in implementing its own plan for the future of the NHS – the Five Year Forward View.</p><p> </p> answering member constituency North East Bedfordshire answering member printed Alistair Burt question first answered 21/09/2015 12:53:10 answering member 1201 label Biography information for Alistair Burt
tabling member	1540 label Biography information for Greg Mulholland